Certain populations are at a higher risk for fibrate-related toxicity and should avoid or use these medications with caution. These include individuals with severe renal or hepatic impairment, those with a history of gallbladder disease, and pregnant or breastfeeding women. The risk of drug-drug interactions should also be considered, particularly with medications such as warfarin and statins.
